We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.74%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
(+9%)
Cap. Flow
-$32.1M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
20.24%
Holding
1,391
New
180
Increased
435
Reduced
508
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lemonade
LMND
|
+$144M |
| 2 |
Meta Platforms (Facebook)
META
|
+$70.5M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$69.1M |
| 4 |
Applied Materials
AMAT
|
+$64.4M |
| 5 |
Amazon
AMZN
|
+$59.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$63.6M |
| 2 |
Apple
AAPL
|
+$62.1M |
| 3 |
Pfizer
PFE
|
+$59M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$45.4M |
| 5 |
Linde
LIN
|
+$43.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.03% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Financials | 9.99% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Ziff Davis
ZD
$2.03B
| $8.91M | 0.03% |
148,005
| – | – |
|
|
BLUE
477
DELISTED
bluebird bio
BLUE
| $8.9M | 0.03% |
12,741
+2,423
| +23% | +$1.89M |
|
|
BMCH
478
DELISTED
BMC Stock Holdings, Inc
BMCH
| $8.9M | 0.03% |
207,900
-5,900
| -3% | -$194K |
|
479
Mid-America Apartment Communities
MAA
$14.4B
| $8.84M | 0.03% |
76,222
-2,438
| -3% | -$281K |
|
480
Xylem
XYL
$25.1B
| $8.77M | 0.03% |
104,278
-24,056
| -19% | -$1.87M |
|
|
ONC
481
BeOne Medicines Ltd
ONC
$39.2B
| $8.76M | 0.03% |
30,598
+2,758
| +10% | +$648K |
|
|
NBIS
482
Nebius Group N.V.
NBIS
$56.4B
| $8.7M | 0.03% |
133,332
-3,358
| -2% | -$200K |
|
483
CDW
CDW
$19.2B
| $8.69M | 0.03% |
72,688
+1,039
| +1% | +$119K |
|
484
CoStar Group
CSGP
$12.8B
| $8.66M | 0.03% |
102,100
-2,790
| -3% | -$222K |
|
485
Ingredion
INGR
$6.25B
| $8.66M | 0.03% |
114,441
-23,500
| -17% | -$1.91M |
|
486
Labcorp
LH
$26.3B
| $8.64M | 0.03% |
53,439
+35,967
| +206% | +$5.7M |
|
487
Quest Diagnostics
DGX
$27.3B
| $8.61M | 0.03% |
75,175
-164,598
| -69% | -$19.4M |
|
|
FRLN
488
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $8.57M | 0.03% |
+36,610
| New | +$9.18M |
|
|
SWAV
489
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $8.54M | 0.03% |
112,700
-22,700
| -17% | -$1.29M |
|
|
SINA
490
DELISTED
Sina Corp
SINA
| $8.51M | 0.03% |
199,600
+15,686
| +9% | +$630K |
|
|
MYOK
491
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.47M | 0.03% |
62,153
-602
| -1% | -$64K |
|
492
Algonquin Power & Utilities
AQN
$4.07B
| $8.44M | 0.03% |
580,500
+48,500
| +9% | +$666K |
|
493
TransUnion
TRU
$14.8B
| $8.41M | 0.03% |
99,998
-13,503
| -12% | -$1.17M |
|
494
C.H. Robinson
CHRW
$18.4B
| $8.32M | 0.03% |
81,426
+31,281
| +62% | +$2.94M |
|
495
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
| $8.32M | 0.03% |
+157,511
| New | +$8.26M |
|
|
SEM
496
DELISTED
Select Medical
SEM
| $8.3M | 0.03% |
739,987
-15,591
| -2% | -$154K |
|
497
Veracyte
VCYT
$3.23B
| $8.29M | 0.03% |
255,000
+74,700
| +41% | +$2.37M |
|
498
Timken Company
TKR
$8.08B
| $8.19M | 0.03% |
151,100
+137,500
| +1,011% | +$7.1M |
|
|
PDCO
499
DELISTED
Patterson Companies, Inc.
PDCO
| $8.18M | 0.03% |
339,500
-40,100
| -11% | -$1.02M |
|
500
Lennox International
LII
$12.5B
| $8.18M | 0.03% |
29,993
-300
| -1% | -$80.1K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2020 Portfolio in Review
As of Q3 2020, Axa held 1,391 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa's Q3 2020 filing shows 180 new, 435 increased, 508 reduced and 107 closed positions. Its largest new stake was Lemonade: 2,299,647 shares worth $114M. The largest sale was Alibaba, an estimated $63.6M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q3 2020 buy was Lemonade: 2,299,647 shares worth $114M.
- Axa added most to Meta Platforms (Facebook) in Q3 2020, an estimated $70.5M increase.
- Axa's biggest Q3 2020 reduction was Alibaba, cutting an estimated $63.6M.
- Axa fully exited Synchrony in Q3 2020, selling an estimated $10.5M.
- Axa's ten largest holdings make up 20% of its $27.7B portfolio in Q3 2020.
- Axa opened 180 new positions and closed 107 in Q3 2020.
- Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.
Based on Axa's 13F filing for Q3 2020, filed 13 Nov 2020.